Home

  • Metabolomics News

    08-15-2017 - Funding Opportunity: RFA-RM-17-015: Metabolomics Core for the Undiagnosed Diseases Network (UDN) Phase II (U01)

    The NIH Common Fund’s Undiagnosed Diseases Network (UDN) is a research study with three overarching goals: 1) improve the level of diagnosis and care for patients with undiagnosed diseases 2) to facilitate research into the etiology of undiagnosed diseases and 3) to promote an integrated and collaborative community of laboratory and clinical investigators prepared to investigate these difficult to diagnose diseases. The NIH is now inviting applications for Phase II of the UDN. One component of the network will be filled via RFA-RM-17-015: Metabolomics Core for the Undiagnosed Diseases Network (UDN) Phase II (U01). The purpose of this funding opportunity is to provide the Metabolomics Core for participants seen through the UDN. The Metabolomics Core will provide clinical expertise and consultation to the UDN network. It will also provide specific expertise in at least two of the following areas: glycans, lipids, and mitochondria. Additionally, the core will serve as a network conduit that will provide access to resources and world class investigators with expertise in metabolomics beyond the scope of the cores’ own expertise.

    08-02-2017 - Four new funding opportunities for Stage II of the NIH Common Fund Metabolomics Program have just been published in the NIH Guide for Grants and Contracts:

    news archive

YOUR FEEDBACK- Please tell us about your experiences with the Metabolomics Workbench.

Events Calendar

more events



Regional Comprehensive Metabolomics Resource Cores (RCMRC)s
Michigan Regional Comprehensive Metabolomics Resource Core (MRC)2
NIH West Coast Metabolomics Center at UC Davis
Eastern Regional Comprehensive Metabolomics Resource Core (ERCMRC)
Southeast Center for Integrated Metabolomics (SECIM)
Resource Center for Stable Isotope-Resolved Metabolomics (RC-SIRM)
Metabolomics Core at Mayo Clinic

more about our RCMRCs


  logo